Literature DB >> 4556543

Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.

L Varga, P M Lutterbeck, J S Pryor, R Wenner, H Erb.   

Abstract

A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in suppressing puerperal lactation and to compare it with stilboestrol and a placebo. At the doses selected ergocryptine and stilboestrol were equally effective.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4556543      PMCID: PMC1788467          DOI: 10.1136/bmj.2.5816.743

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  23 in total

1.  Treatment of non-puerperal galactorrhoea with an ergot alkaloid.

Authors:  P M Lutterbeck; J S Pryor; L Varga; R Wenner
Journal:  Br Med J       Date:  1971-07-24

2.  Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-alpha-Ergokryptine (CB 154).

Authors:  E Billeter; E Flückinger
Journal:  Experientia       Date:  1971-04-15

3.  Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice.

Authors:  R Yanai; H Nagasawa
Journal:  Experientia       Date:  1970-06-15

4.  The biosynthesis of human growth hormone and prolactin.

Authors:  H Friesen; H Guyda; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1970-12       Impact factor: 5.958

5.  Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.

Authors:  R Yanai; H Nagasawa
Journal:  J Natl Cancer Inst       Date:  1970-12       Impact factor: 13.506

6.  Growth inhibition of rat mammary carcinoma and endocrine changes produced by 2-Br-alpha-ergocryptine, a suppressor of lactation and nidation.

Authors:  J C Heuson; C Waelbroeck-van Gaver; N Legros
Journal:  Eur J Cancer       Date:  1970-10       Impact factor: 9.162

7.  [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].

Authors:  J L Pasteels; A Danguy; M Frérotte; F Ectors
Journal:  Ann Endocrinol (Paris)       Date:  1971 Jan-Feb       Impact factor: 2.478

8.  Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.

Authors:  E E Cassell; J Meites; C W Welsch
Journal:  Cancer Res       Date:  1971-07       Impact factor: 12.701

9.  Plasma prolactin activity in inappropriate lactation.

Authors:  I A Forsyth; G M Besser; C R Edwards; L Francis; R P Myres
Journal:  Br Med J       Date:  1971-07-24

10.  Prolactin: evidence that it is separate from growth hormone in human blood.

Authors:  A G Frantz; D L Kleinberg
Journal:  Science       Date:  1970-11-13       Impact factor: 47.728

View more
  17 in total

1.  Development of pituitary adenoma treatment--a critical essay.

Authors:  A M Landolt
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

2.  Hypothermic action of bromocriptine.

Authors:  D B Calne; L E Claveria; J L Reid
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

3.  The history of the treatment of pituitary adenomas.

Authors:  Nicholas F Maartens
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

Review 4.  Pituitary-gonadal axis: historical notes.

Authors:  J Lindholm; E Husted Nielsen
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 5.  Treatments for suppression of lactation.

Authors:  Olufemi T Oladapo; Bukola Fawole
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 6.  Use of bromocriptine in the inhibition of puerperal lactation.

Authors:  R Rolland
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

7.  Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.

Authors:  B H Yuen; H J Pendleton; S Blair
Journal:  Can Med Assoc J       Date:  1977-10-22       Impact factor: 8.262

8.  Bromocriptine--fact or expensive fancy.

Authors: 
Journal:  Br Med J       Date:  1977-04-02

9.  Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.

Authors:  F Scapin; S Buonaccorsi; G Tronconi; G Pellicciotta; A E Pontiroli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.